Investing

Lithium Argentina Closes US$180 Million Ganfeng Expansion Deal

Lithium Argentina has solidified its financial footing after closing a 180 million dollar investment deal with Ganfeng Lithium. This strategic move arrives as an unsecured convertible note featuring a four percent annual coupon, allowing the Swiss-based miner to significantly clean up its books. By combining these new funds with available cash, the company plans to completely pay off 259 million dollars in existing convertible notes that were set to mature in early 2027.

Chief Executive Officer Sam Pigott noted that the infusion of capital combined with steady distributions from the Cauchari-Olaroz project creates a much healthier balance sheet. With lower net debt and a more favorable cost of capital, the company is better positioned for long term growth. For Ganfeng, the deal deepens an already close relationship; should the notes be fully converted into shares at twelve dollars and fifty cents each, the Chinese producer would see its ownership stake climb from roughly nine percent to over sixteen percent.

Beyond the immediate financial relief, this agreement paves the way for deeper operational integration between the two firms. They are currently working toward a joint venture involving the Pozuelos-Pastos Grandes project in Argentina’s Salta province, which they hope to finalize by late 2026. Meanwhile, their primary asset at Cauchari-Olaroz continues to show strength, maintaining high output levels despite scheduled maintenance shutdowns earlier this year.

Looking ahead, both partners are focusing on a massive stage two expansion aimed at adding another 45,000 tons of annual capacity. To achieve this, they are employing a modular direct lithium extraction approach using specialized equipment provided by Ganfeng. The project recently received approval from the Argentine government under a special incentive regime designed to provide fiscal stability and tax benefits for large scale investments, ensuring that the expansion can proceed with reduced regulatory risk.